跳至主要内容
临床试验/JPRN-jRCTs021190020
JPRN-jRCTs021190020已完成1 期

Evaluation of improvement of bacterial flora in pregnant women by lactoferrin tablets

Miura Hiroshi0 个研究点目标入组 8 人开始时间: 2020年2月18日最近更新:
适应症

试验速览

阶段
1 期
状态
已完成
发起方
入组人数
8

研究概览

简要总结

Oral administration of lactoferrin enteric coated tablets for vaginitis or cervicitis in pregnant women inproved the vaginal flora, but no statistically significant difference was observed in comparison with the control group. This is thought to be due to the small number of cases. Since there were no cases of spontaneous preterm birth, it was unclear whether oral administration of lactoferrin enteric coated tablets contributed to the prevention of preterm birth. There was no adverse events.

研究设计

研究类型
Interventional

入排标准

年龄范围
>= 20age old 至 < 50age old(—)
性别
Female

入选标准

  • 1) Maternal age: 20 years old or older, under 50 years
  • 2) Pregnant women who plan to deliver in our department
  • 3) Patients who have been diagnosed with intractable vaginitis or cervicitis, and who have not improved their vaginal discharge findings with conventional treatment

排除标准

  • If not gain consent

研究者

发起方
Miura Hiroshi

相似试验